pirtenidine: effective for the control of plaque & gingivitis; structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| ID Source | ID |
|---|---|
| PubMed CID | 65879 |
| CHEMBL ID | 1194161 |
| SCHEMBL ID | 2108103 |
| MeSH ID | M0173272 |
| Synonym |
|---|
| pirtenidine |
| n,1-dioctylpyridin-4-imine |
| unii-s6on6743tm |
| pirtenidinum |
| pirtenidinum [latin] |
| 103923-27-9 |
| pirtenidina |
| 1-octanamine, n-(1-octyl-4(1h)-pyridinylidene)- |
| s6on6743tm , |
| pirtenidina [spanish] |
| pirtenidine [inn] |
| 1,4-dihydro-1-octyl-4-(octylimino)pyridine |
| CHEMBL1194161 |
| n-(1-octyl-4(1h)-pyridinylidene-1-octanamine |
| SCHEMBL2108103 |
| DTXSID90146143 |
| phosphomycin sodium |
| Q27288737 |
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 1 (20.00) | 18.7374 |
| 1990's | 4 (80.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 5 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||